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Supplemental materials and methods 
 
 
Nuclear extracts from NIH 3T3 mouse fibroblasts 
Nuclear extracts were prepared by swelling the cells in 100 mM Tris-HCl pH 8.8/ 10 
mM DTT and subsequent hypotonic lysis (10 mM EDTA, 1 mM EGTA, 10 mM 
Hepes pH 6.8, 0.2% Triton-X 100, 0.5 mM DTT, protease inhibitor cocktail). After 
centrifugation for 5 minutes at 2,500 g and 4°C, the supernatant was stored as 
cytosolic fraction. The pellet was washed once with the same buffer and resuspended 
in 1 mM EDTA/1 mM EGTA/10 mM Hepes, pH 6.8/10% glycerol/300 mM NaCl/ 
0.5 mM DTT and protease inhibitor cocktail (Roche Applied Science). Samples were 
incubated for 20 minutes on ice and centrifuged for 20 minutes at 16,000 g and 4°C. 
The supernatant was stored as the nuclear fraction at -70°C. 
 
 
Co-immunoprecipitation analysis  
For co-immunoprecipitation with HA-REV-ERB , 20 μg of nuclear protein extract 
were incubated in the presence of 0.1% Triton-X 100 with 3 μl HA antibody 
(Roche) or 15 μl HA agarose (Sigma-Aldrich) in rotation over night at 4°C. HA 
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antibody was captured with protein A agarose beads for two hours at 4°C. Beads were 
collected by centrifugation and washed four times using lysis buffer supplemented 
with 1% Triton-X 100 and 150 mM NaCl. Laemmli sample buffer was added, 
samples were boiled and subsequently subjected to SDS-PAGE (Laemmli 1970). 
 
Quantification of the Area under the curve 
 
Bioluminescence counts over several days were quantified by measuring the area 
under the curve (AUC) as a measure of the total reporter activity using Prism4 
software (GraphPad software Inc., La Jolla, CA). To compare the effects of the 
overexpressed proteins on luciferase reporter expression, the AUC of the luciferase 
reporter vector alone was defined as 100 % and the AUC values of the co-
transfections were calculated relative to 100 %. 
 
Succinylacetone and hemin treatment 
Cells were switched 24 hrs after transfection to serum free medium supplemented 
with or without succinylacetone (5 mM; Sigma-Aldrich) overnight. For the hemin 
(Sigma-Aldrich) treatment, cells were treated with either solvent or hemin (6 μM) for 
6 hrs. Nuclear extracts were prepared as described above. An aliquot of cells from the 
treated cultures was taken for RNA extraction. 
 
Blood glucose determination 
Blood samples were collected in clotting activator coated capillaries (Microvette 100, 
Sarstedt) and serum was recovered after centrifugation for 10 min at 3,300 g. Glucose 
was measured with the glucose-hexokinase reagent (Sigma-Aldrich) and normalized 
to a control serum used in each experiment. 
                                                                                                            Schmutz et al. 3 
 
Supplemental figure legends 
 
Supplemental figure 1. PER2 co-immunoprecipitates better than PER1 with nuclear 
receptors in vitro 
(A-C) HA-tagged hormone receptors involved in the circadian oscillator mechanism 
(A), other nuclear receptors (B), or HA-CRY1 (C) were immunoprecipitated from 
NIH 3T3 nuclear extracts (right panels) in the presence of either PER2-V5 or PER1-
V5. Left panels show the input of protein as used in each assay. Expression vectors 
used for co-transfection as well as antibodies used for Western blot analysis are 
indicated. 
 
Supplemental figure 2. In vitro characterization of the PER2/nuclear receptor 
interaction 
(A, B, C) Left panels show the input of the indicated proteins as used in each assay. 
Right panels show the co-immunoprecipitation. The immunoprecipitated proteins 
were analyzed by Western blot. Antibodies used for detection and 
immunoprecipitation are indicated. Reactions with extract and beads alone were used 
as negative control for unspecific background binding. 
(A) Immunoprecipitation of HA-CRY1 using HA agarose.  
(B) Immunoprecipitation of HA-REV-ERB  protein using HA antibody. Extracts 
were incubated with agarose A beads with or without HA antibody. 
(C) Immunoprecipitation of wild-type or truncated HA-REV-ERB  using HA 
agarose. 
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(D) Quantification of results obtained from co-immunoprecipitation experiments 
using NIH 3T3 nuclear extracts. The amount of co-immunoprecipitated V5-tagged 
protein was normalized to the amount of protein available for co-immunoprecipitation 
(as seen in the input panels). This value was normalized to the amount of 
immunoprecipitated HA-nuclear receptor. The wild-type PER2-V5/HA-nuclear 
receptor ratios were set to 1 and all other values were calculated relative to it, with n = 
4 and *P < 0.001 indicating significance (One-way ANOVA). Error bars represent 
standard deviation. 
(E) Dose-dependent effects of PER1, PER2 and PER2 mLXXLL on Rev-erb  luc and 
Bmal1 luc expression. NIH 3T3 cells were transfected with the indicated reporter 
vector either alone or together with the specified expression vector. 48 hrs after 
transfection, cells were synchronized with dexamethasone and luciferase activity of 
each culture was monitored. Data are plotted as mean + SD (n = 2, representative 
experiment out of three independent experiments).  
(F) Dose response curves of increasing amounts of PER1 or PER2 on Rev-Erb  or 
Bmal1 luciferase reporter genes. Areas under the curves were quantified for each 
reporter with or without expression vector, normalized and plotted against each other. 
Note that PER1 and PER2 both diminish the expression of Rev-Erb  luc in a dose 
dependent manner, whereas they act differently on Bmal1 luc expression. After 
reaching a peak of bioluminescence activity, even higher amounts of PER2 
expression vector abolished this activation. ** P < 0.01, *** P < 0.001 indicating 
significance (One-way ANOVA). Error bars represent standard deviation (data 
combined from 8 independent experiments). 
 
Supplemental figure 3. Controls for chromatin immunoprecipitation experiments 
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(A) Analysis of circadian mRNA accumulation in the livers of wild-type (black), Rev-
Erb -/- (green), and Per2Brdm1 (red) mutant animals. Total RNA was prepared from 
animals held in a LD 12:12 cycle. The relative amounts of Bmal1, Rev-Erb  and 
Hnf1 mRNA were measured by Taqman real-time RT-PCR. Plotted are the mean 
values  SEM from four independent experiments. 
(B and C) Chromatin immunoprecipitation analysis of chromatin prepared at 4 hrs 
intervals from wild-type, Rev-Erb -/- and Per2Brdm1 mutant animals with the indicated 
antibodies. Specific Taqman probes were used to detect the indicated promoter 
regions. Plotted are the mean values  SEM from three independent experiments.  * 
represents the regulatory region preceding the Rev-Erb  knockout allele. 
 
Supplemental figure 4. Analysis of mRNA and proteins levels in the liver 
(A) Genotyping of wild-type, homozygous and heterozygous Per2Brdm1, Rev-Erb -/-, 
Rev-Erb +/- and Rev-Erb -/-/Per2 mutant mice by PCR using genomic DNA obtained 
from tail biopsies. 
 (B-D) Total RNA was prepared from wild-type (black), Rev-Erb -/- (green), 
Per2Brdm1 (blue) and Rev-Erb -/-/Per2 mutant (red) animals held in LD 12:12. The 
relative amounts of Per2 (B) and Rev-Erb  (C), Dbp (D) and Rev-Erb  (E) mRNA 
were measured by Taqman real-time RT-PCR. Plotted are the mean values  SEM 
from three independent experiments; ZT0 is double plotted. 
(F) Nuclear extracts were analyzed by Western blot analysis using the indicated 
antibodies. 
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Supplemental figure 5. Analysis of free-running period length of wild-type, Rev-
Erb -/-, Per2Brdm1 and Rev-Erb -/-/Per2 mutant animals 
(A and B, D) Representative locomotor activity records of Per2Brdm1 (A), Rev-Erb -/- 
(B) and Rev-Erb -/-/Per2 mutant (D) animals.  The top bar indicates light and dark 
periods. The dark shaded areas represent darkness. Note the difference in behavior 
under LD 12:12 and constant conditions (DD). The side bar in panel D indicates days 
of arrhythmic locomotor activity of this animal. 
(C) Period length of wild-type, Rev-Erb -/-, Per2 mutant and Rev-Erb -/-/Per2 double 
mutant animals as determined by 2-periodogramm analysis. ***P < 0.001, *P < 0.05 
indicating levels of significance (One-way ANOVA). 
 
Supplemental figure 6. Impact of Per2 on feeding behavior, glucose homeostasis, and 
regulation of G6Pase expression 
(A) Chromatin immunoprecipitation experiment to detect circadian PER2 binding at 
the G6Pase promoter. Co-immunoprecipitated DNA fragments were quantified by 
Taqman real-time PCR. 
(B) Distribution of feeding activity (regular chow diet) between light and dark periods 
in the indicated genotypes. 100 % corresponds to the total of food consumed per day 
(n = 12, mean  SEM). 
(C) Resting blood glucose of wild-type (black), Rev-Erb -/- (green), Per2Brdm1 mutant 
(blue) and Rev-Erb -/-/Per2Brdm1 double mutant (red) animals. Plotted values are the 
mean values  SEM (n = 6); ZT0 is double plotted. 
 
Supplemental figure 7. PER2 modulates the effect of REV-ERB  on Bmal1 
luciferase 
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NIH 3T3 cells were transfected with a Bmal1 luciferase reporter either alone or 
together with increasing amounts of HA-Rev-Erb  expression vector (grey) or a 
constant amount of Per2-V5 expression vector (red). Dashed lines in the lower panel 
represent co-transfection of the same increasing amounts of HA-Rev-Erb  together 
with a constant amount of Per2-V5. Cells were synchronized by a dexamethasone 
shock and luciferase activity was recorded. Data are plotted as mean only 
(representative experiment out of three independent experiments). 
 
Supplemental figure 8. Heme does not affect the interaction of REV-ERB  and PER2 
Immunoprecipitation of HA-REV-ERB  with HA agarose. After co-transfection, 
cells were pretreated with succinylacetone overnight and then treated with or without 
hemin for 6 hrs.  The treatment is indicated for each lane. The relative amounts of 
Alas1 mRNA and Bmal1 mRNA derived from an aliquot from the same culture were 
measured by Taqman real-time RT-PCR and normalized to the corresponding Gapdh 
levels (lower panels). Alas1 mRNA levels are increased or decreased in response to 
lower or higher than optimal intracellular hemin concentrations, respectively (for 
example: Raghuram et al., 2007). 
 
                                                                                                            Schmutz et al. 8 
Supplemental references 
 
  
Hampp G, Ripperger JA, Houben T, Schmutz I, Blex C, Perreau-Lenz S, Brunk I, 
Spanagel R, Ahnert-Hilger G, Meijer JH et al. 2008. Regulation of 
monoamine oxidase A by circadian-clock components implies clock influence 
on mood. Curr Biol 18: 678-683. 
Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head 
of bacteriophage T4. Nature 227: 680-685. 
Langmesser S, Tallone T, Bordon A, Rusconi S, and Albrecht U. 2008. Interaction of 
circadian clock proteins PER2 and CRY with BMAL1 and CLOCK. BMC 
Mol Biol 9: 41. 
Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, and Schibler U. 2004. Circadian 
gene expression in individual fibroblasts: cell-autonomous and self-sustained 
oscillators pass time to daughter cells. Cell 119: 693-705. 
 
 
Table S1 Vectors    
    
Construct Based on accession number Nuclear receptor nomenclature Comments 
    
pSCT1 (Langmesser et al., 2008)    
pSCT1 Per2V5 NM_011066   
pSCT1 Per1V5  NM_011065   
pSCT1 HACry1 NM_007771 -  
pSCT1 HARev-ErbD NM_145434 NR1D1  
pSCT1 HARorD BC003757 NR1F1  
pSCT1 HAErD  NM_007956 NR3A1  
pSCT1 HANurr1 NM_013613  NR4A2  
pSCT1 HAPparD NM_011144    NR1C1  
pSCT1 HAHnf4D NM_008261 NR2A1  
pSCT1 HARxrD NM_011305 NR2B1  
pSCT1 HAThrD NM_178060 NR1A1  
pSEAP (Hampp et al., 2008) - -  
Bmal1 luciferase (Nagoshi et al., 2004) - -  
Rev-ErbD luciferase - - To obtain Rev-ErbD-luciferase, a 6.6 kbp fragment of the 
mRev-ErbD gene, starting at the unique MluI restriction 
enzyme site (about 3.5 kbp upstream from the transcriptional 
start site WR WKHEHJLQQLQJRI H[RQZDVPRGLILHGDW WKH¶
site and cloned into the pGL3 basic vector (Promega, 
Madison, USA). This constructs expresses after appropriate 
splicing an in frame fusion protein containing the first 16 amino 
acids of mREV-ERBD and the firefly luciferase. 
Bmal1 ext luciferase   ¶ extension of Bmal1 luciferase (Nagoshi et al., 2004) by 822 
bp to include the PPARD-regulatory site (Canaple et al., 2006). 
 
 
Table S1. Vectors used in this study. Corresponding accession numbers and the nuclear receptor nomenclature are indicated. 
Table S2 Cloning 
   
Construct Primer Name Sequence Mutation 
    
pSCT1 Per2V5 (ACCAA) mLCCLL Per2(ACCAA)-FW 5`-GAG CCA GGC ATG CTG CGC AGC GCT GGC AGA GAG GGT AC-3` mutation of aa L306, L309 & 
L310 to alanine residues site-directed mutagenesis Per2(ACCAA)-RV 5`-GTA CCC TCT CTG CCA GCG CTG CGC AGC ATG CCT GGC TC-3` 
    
pSCT1 Per2V5 (LEAAA) mLLNLLL Per2(LEAAA)-FW 5`-CAA GTG ACC TGC TCG AGG CGG CGG CCG GCG AGG ACC TCT GCT C-3` mutation of aa N1052E and, 
L1053A , L1054A, L1055A site-directed mutagenesis Per2(LEAAA)-RV 5`-GAG CAG AGG TCC TCG CCG GCC GCC GCC TCG AGC AGG TCA CTT G-3` 
    
pSCT1 Per2V5 mLXXLL 
  combination of ACCAA and 
LEAAA mutations    
    
pSCT1 PER2V5 'LCCL PER2(LCCL)-S 5`-CCT GGT CAA GGT GCA AGA GCA GCA GGG TGC TGA GAG CCA GGA GAG GGT ACA C-3` deletion of aa L306-A312 
deletion PER2(LCCL)-AS 5`-CCG AGT GTA CCC TCT CCT GGC TCT CAG CAC CCT GCT GCT CTT GCA CCT TGA-3`  
    
pSCT1 PER2V5 'LNLL PER2(LNLL)-S 5`-CAA CGA GCC CTC AGA CGG C-3` deletion of aa T1038-T1063 
deletion PER2(LNLL)-AS 5`- TGA GCC GTC TGA GGG CTC GTT GCA TG-3`  
    
pSCT1 PER2V5 'LXXL   combination of 'LCCL and 
'LNLL deletions deletion   
    
pSCT1 HARev-ErbD 'LBD   deletion of aa I290-Q615 
out of frame deletion    
    
pSCT1 HARev-ErbD (456 KA) Rev-ErbD(KtoA)-FW 5`-GGT GGT AGA GTT TGC CGC TCA CAT CCC AGG CTT CC-3` mutation of aa K456 to alanine 
site-directed mutagenesis Rev-ErbD (KtoA)-RV 5`-GGA AGC CTG GGA TGT GAG CGG CAA ACT CTA CCA CC-3`  
    
pSCT1 HARev-ErbD 'DBD Rev-ErbD ('DBD)-S 5`-CCG GTA CCG AGC AGC CTG TGC CCT-3` deletion of aa T2-N231 
deletion Rev-ErbD ('DBD)-AS 5`-CTA GAG GGC ACA GGC TGC TCG GTA-3`  
    
pSCT1 HARev-ErbD'C Rev-ErbD ('C)-FW 5`-CATGTATCCCCATGGACGCAGCGG-3` deletion of aa K588-Q615 
cloning by PCR Rev-ErbD ('C)-RV 5`-GGATCCGGTGAAGCGGGAAGTCTC-3`  
    
pSCT1 HAPparDK292A) PparD(KtoA292)-FW 5`-GAG CTC ACA GAA TTT GCC GCG GCT ATC CCA GGC TTT GC-3` mutation of aa K292 to alanine 
site-directed mutagenesis PparD(KtoA292)-RV 5`-GCA AAG CCT GGG ATA GCC GCG GCA AAT TCT GTG AGC TC-3`  
    
pSCT1 HAPparD'H12 PparD('H12)-S 5`-GCT GCA CCC ATA ACA CGT-3` deletion of aa L459-Y468 
deletion PparD('H12)-AS 5`-ACG TGT TAT GGG TGC AGC-3`  
 
Table S2. Strategies to change specific regions or amino acids of the indicated expression vectors.  
Table S3 Primer list 
  
Primer for ChIP Sequence 
Bmal1 (+50) FW ¶-CAGCGAGCCACGGTGA-¶ 
Bmal1 (+50) RV ¶-CCCGAGACGGCTGCT-¶ 
Bmal1 (+50) TM ¶-FAM-CCGCAGCCATGCCGACAC-BHQ1-¶ 
Bmal1 (-1,600) FW ¶-GCCAATTCACATTTCAACCA-¶ 
Bmal1 (-1,600) RV ¶-GACACAAGGCAGCATTTCAA-¶ 
Bmal1 (-1,600) TM ¶-FAM-TGCAAAGGGCTGGACATGGG-BHQ1-¶ 
Rev-Erb  FW  ¶-TCACATGGTACCTGCTCCAG-¶ 
Rev-Erb  RV ¶-CTTTTGCCCGAGCCTTTC-¶ 
Rev-Erb  TM ¶-FAM-ACAGAGGGCTCTGCGCAGGC-BHQ1-¶ 
Hnf1  FW  ¶-GCAAGGCTGAAGTCCAAAGT-¶ 
Hnf1  RV ¶-ATTGGAGCTGGGGAAATTCT-¶ 
Hnf1  TM ¶-FAM-CCCTTCGCTAAGCGCACGGA-BHQ1-¶ 
G6Pase FW ¶-TGCCCTTGCAAGAGTCATGGTTGA-¶ 
G6Pase RV ¶-AGTGCTAGAGGCTGCCCTCC-¶ 
G6Pase TM ¶-FAM-AGCCAGGCCAGAGGCCCAGGGC-BHQ1-¶ 
Primer for genotyping Sequence 
Per2 FW 5`-GCTGGTCCAGCTTCATCAACC-3` 
Per2 RV (wild-type) 5`-GAACACATCCTCATTCAAAGG-3` 
PKGhprt RV  5`-CGCATGCTCCAGACTGCCTTG-3 
Rev-Erb  FW 5`-CCAGGAAGTCTACAAGTGGCCATGGAAGA-3` 
Rev-Erb RV (wild-type) 5`-CACCTTACACAGTAGCACCATGCCATTCA-3 
lacZ RV 5`-AAACCAGGCAAAGCGCCATTCGCCATTCA-3` 
Primer for real-time RT PCR Sequence 
Hnf1  FW ¶-GCGGGCCGCTCTGTACACC-¶ 
Hnf1  RV ¶-CCTGCCCTGCGTGGGTGA-¶ 
Hnf1  TM ¶-FAM-ACGTCCGCAAGCAGCGAGAGGTGGC-BHQ1-¶ 
G6Pase FW ¶-ACTGTGGGCATCAATCTCCT-¶ 
G6Pase RV ¶-CGTTGTCCAAACAGAATCCA-¶ 
G6Pase TM ¶-FAM-TGGGTGGCAGTGGTCGGAGA-BHQ1-¶ 
Pepck FW ¶-GAAGAAAGGTGGCACCAGAG-¶ 
Pepck RV ¶-GGATGACCTTGGCAGAGAAG-¶ 
Pepck TM ¶-FAM-TGCCTCCTCAGCTGCATAACGGT-BHQ1-¶ 
Alas FW ¶-GGTGGAGGGATCGGTGAT-¶ 
Alas RV ¶-TGGCAATGTATCCTCCAACA-¶ 
Alas TM ¶-FAM-CGCTTGGTAAAGCGTTCGGCTG-¶ 
 
-time PCR. FAM: 6-fluorescein; BHQ1: black hole quencher1 
